Blog

Allogenic mesenchymal stem cells for dilated cardiomyopathy – Nature.com


Nature.com

Allogenic mesenchymal stem cells for dilated cardiomyopathy
Nature.com
Patients with chronic nonischaemic dilated cardiomyopathy (NIDCM) treated with allogenic (allo) human mesenchymal stem cells (hMSCs) show improved cardiac function and quality of life compared with those treated with autologous (auto) hMSCs.

2017-02-16 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.